Eva Prchalová
Charles University in Prague
8 Papers
13 Citations
Eva Prchalová is an academic researcher from Charles University in Prague. The author has contributed to research in topics: HaCaT & Transdermal. The author has an hindex of 4, co-authored 8 publications.
Chat about Author
Papers
Medicinal applications of perfluoroalkylated chain-containing compounds.
TL;DR: This review is to provide an overview of synthesized compounds possessing perfluoroalkylated or polyfluorinated chains that have been tested for bioactivity or as potential drug candidates for the treatment of various diseases.
60
Galactosyl Pentadecene Reversibly Enhances Transdermal and Topical Drug Delivery.
Monika Kopečná,Miloslav Machacek,Eva Prchalová,Petr Štěpánek,Pavel Drašar,Martin Kotora,Kateřina Vávrová +6 more
TL;DR: Galactosyl pentadecene A15 is a potent enhancer with low toxicity and reversible action on skin penetration/permeation enhancers based on amphiphilic galactose derivatives.
21
Sphingosine and clavaminol H derivatives bearing fluorinated chains and their cytotoxic activity
TL;DR: Microwave induced cross-metathesis of perfluoroalkylated propenes with a substituted allyl alcohol is a simple and straightforward method for the synthesis of sphingosine derivatives possessing perfluoralkyl chains as mentioned in this paper.
13
Sphingosine and Clavaminol H Derivatives Bearing Fluorinated Chains and Their Cytotoxic Activity.
TL;DR: In this paper, the authors proposed a method for deprotection and functionalization of derivatives (III, VI, and VI) by standard procedures, which can be easily deprotected and further functionalized by standard procedure.
Patent
15β-substituted estrone derivatives as selective inhibitors of 17β-hydroxysteroid-dehydrogenases, method of preparation and use thereof
Martin Kotora,Eva Prchalová,Adamski Jerzy,Moeller Gabriele,Ondřej Štěpánek,Bartunek Petr,David Sedlák,Marian Hajduch,Dzubak Petr +8 more
- 14 Dec 2017
TL;DR: In this paper, the authors proposed 15β-substituted derivatives of estrone of general formula I where R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R17, R18, R19, R20, R21, R22, R23, R24, R25, R26, R27, R28, R29, R30, R31